siRNA, Anti-SLC5A1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT21235WQ-2OMe)

The product SIRGT21235WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC5A1 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC5A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_000343.3; NM_001256314.1
Alternative Names D22S675; NAGT; SGLT1
Related Diseases Glucose/Galactose Malabsorption
Purification HPLC
Target Gene
Gene ID 6523
Uniprot ID P13866
Sub Cat Target Species Modification Scale  
SIRGT22235WQ-2F SLC5A1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT23235WQ-2MOE SLC5A1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT24235WQ-LNA SLC5A1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT21235WQ-RB SLC5A1 Human Ribo-modified Inquiry
SIRGT22235WQ-BB SLC5A1 Human Backbone-modified Inquiry

Related Products